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Dual mating strategy hypothesis has been influential in research of human mate choice for 
twenty years. According to dual mating hypothesis women prefer different attributes in 
men in different phases of menstrual cycle. This may have been adaptive as it can lead to 
situation where the offspring is fathered by genetically strong male, who may not be 
willing to invest in the offspring and women may have gotten help in rearing the offspring 
from another man, not knowing that he is not the biological father. Although first studies 
found support for the hypothesis, recently it has been challenged as earlier studies 
reporting significant findings have been criticized for their methodology and studies, using 
larger sample sizes in comparison with earlier studies, have failed to find support for dual 
mating hypothesis. In the current study dual mating strategy hypothesis was tested using 
two potential cues of genetic quality, facial masculinity and putative human chemosignal 
androstadienone. Current study was conducted as placebo controlled, double-blind 
between-subjects design. Eighty-one (81) self-reported heterosexual females differing in 
fertility status (fertile phase of menstrual cycle n=17, non-fertile phase of menstrual cycle 
n=30 and use of hormonal contraceptives n=34) participated in the study. Participants task 
was twofold: first to rate attractiveness of individual pictures of male faces, and to choose 
the more attractive face from morphed face pairs. Both evaluations were done twice, once 
before and once after the exposure to androstadienone or placebo treatment. Facial 
attractiveness was rated from individual pictures and masculinity preference was tested 
using forced choice task with face pairs consisting of two morphed versions of same face, 
one morphed to be more masculine and the other morphed to be more feminine. At half 
point of the rating task half of the participants received androstadienone (n=41) and half 
were in placebo condition (n=40) to test if androstadienone would increase perceived 
attractiveness. Analyses showed no preference shift towards masculinity in fertile 
compared to non-fertile phase of menstrual cycle, and no decrease in masculinity 
preference was found in hormonal contraceptive users as dual mating theory predicts. 
Also, no evidence was found that androstadienone increases female perceptions of male 
face attractiveness as some studies have found. Our results found no evidence for the link 
between women’s preference for cues of masculinity and their hormonal status, adding 
up to the growing body of research failing to find support for dual mating strategy 
hypothesis. Regarding androstadienone we did not find support for its role as chemosignal 
of genetic quality, adding up to controversial field of results. 
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III 
 
HEADING                  I 
 
ABSTRACT                 II 
 
TABLE OF CONTENTS               III 
 
 
1. INTRODUCTION ......................................................................................................................... 1 
1.1. Mate choice ....................................................................................................................... 3 
1.2. Potential cues of male reproductive fitness ...................................................................... 5 
1.2.1. Facial attractiveness and dimorphism ........................................................................ 5 
1.2.2. Chemosignals .............................................................................................................. 6 
1.2.3. Dark side of masculinity .............................................................................................. 7 
1.3. Dual mating strategy .......................................................................................................... 8 
1.3.1. Critique of dual mating hypothesis ............................................................................. 9 
1.4. Current study ................................................................................................................... 10 
2.METHODS ................................................................................................................................. 12 
2.1. Participants ...................................................................................................................... 12 
2.2. Materials .......................................................................................................................... 12 
2.2.1. Androstadienone ...................................................................................................... 12 
2.2.2. Individual pictures ..................................................................................................... 12 
2.2.3. Picture pairs .............................................................................................................. 13 
2.3. Procedure ......................................................................................................................... 14 
2.3. Statistical analyses ........................................................................................................... 15 
2.3.1. Variables .................................................................................................................... 16 
2.3.2. Analyses of odor pleasantness and intensity ............................................................ 16 
2.3.3. Analyses of attractiveness evaluations and masculinity preference ........................ 17 
3. RESULTS ................................................................................................................................... 19 
3.1. Odor masking ................................................................................................................... 19 
3.2. Between group differences in perceived attractiveness and masculinity preference .... 19 
3.2.1. Attractiveness ratings ............................................................................................... 19 
3.2.2. Masculinity preference ............................................................................................. 19 
4. DISCUSSION ............................................................................................................................. 21 
4.1. Limitations of the study ................................................................................................... 23 
4.2. Conclusion ........................................................................................................................ 26 
REFERENCES ................................................................................................................................ 28 
1 
 
1. INTRODUCTION 
 
Human mate choice is a complex problem. Pool from which to choose a potential mate 
is nowadays seemingly infinite, desirable attributes are numerous and all the desired 
attributes are seldomly found in one individual, hence compromises are often made. 
Both sexes prefer healthy appearance, signs of intelligence and kindness in potential 
mate but there are also sex differences as males are more attracted to physical 
attributes, whereas women tend to prefer attributes linked to high social status (Buss, 
1989). According to evolutionary psychology sexes differ in their potential 
reproductive capability and have thus faced different adaptive problems in 
evolutionary history. Different adaptive problems have led to different preferences in 
mate choice to solve these problems. From evolutionary point of view optimal strategy 
for males is more straightforward as there are fewer biological constraints on potential 
number of offspring, female mate choice is harder to explain as reproduction bears 
significant cost and hinders future reproduction. One of the theories tackling female 
mate choice from evolutionary perspective is dual mating theory, that suggests that to 
get the good genes that increase the survival or reproductive success of  the offspring 
and to get support for rearing the offspring, women should prefer cues of genetic 
quality in the fertile phase of the menstrual cycle and prefer cues of parental 
investment in the non-fertile phase.  On a special note, when referring to men and 
women in this thesis, biological sex determined by gamete size, is meant. Thus, “men” 
refers to sex with smaller gametes and “women” to sex with bigger gametes. No stand 
is taken regarding gender or gender identity as they are out of the scope of current 
study. 
Choosing a mate has crucial role in reproductive success, as rearing an offspring itself is 
costly in terms of resources and time. Even though offspring inherits roughly half of 
his/her alleles from each parent, there lies a difference in parental invest, most notably 
women’s cost of producing larger gametes, and pregnancy (Trivers, 1972). As this cost 
is greater for women, sexual strategies theory (Buss & Schmitt, 1993) predicts that 
women should prefer cues of both, genetic quality and parental investment in order to 
produce genetically as high quality offspring as possible and receive support in rearing 
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them. However, for men with high genetic quality optimal mating strategy is not to 
form a long-term relationship, but rather to have as many short-term relationships as 
possible, as benefit of potential offspring outweigh cost of reproduction (Buss & 
Schmitt, 1993). Sexes thus differ in their optimal mating strategy according to 
evolutionary psychology.  
Dual mating strategy hypothesis suggests that in scenario described in previous 
chapter natural selection could have favoured women who during fertile phase of 
menstrual cycle prefer cues of good genes and in non-fertile phase cues of willingness 
to invest in offspring (Pillsworth & Haselton, 2006). Although in many primate species 
ovulation is advertised by for example sexual swelling, in humans no swelling, or other 
kind of advertisement, happens (Havlíček, Dvořáková, Bartoš, & Flegr, 2006). As human 
ovulation is “concealed” and conception is possible for only in a limited time window 
near ovulation, according to dual mating hypothesis this enables an alternative mating 
strategy to the conventional pair bonding. Women could get parental investment by 
forming a long-term relationship with individual willing to invest and obtaining the 
“good genes” via adultery during fertile phase of menstrual cycle with a male of high 
genetic value. It is noteworthy that to utilize this hypothetical strategy, women do not 
need make conscious decision, but rather subtle changes in behaviour near ovulation 
can be sufficient for obtaining the “good genes”. Also, although dual mating theory 
predicts that female preference shifts depending on cycle phase, these preference 
shifts do not dictate human behaviour, but can be seen statistically at the level of 
population.  
Evolutionary psychology differs from traditional psychology as it aims to explain 
psychological phenomena with ultimate explanations. Ultimate explanations aims to 
answer question why a trait exist, by explaining its adaptive importance in 
evolutionary history (Scott-Phillips, Dickins, & West, 2011). A trait that has increased 
either survival or reproductive rate has increased the fitness of the individual and 
hence been beneficial for passing on the genes.  Traditional psychology aims to explain 
phenomena in proximate level, answering question like how does this phenomenon 
work. As ultimate and proximate explanations answer to different questions, they 
complement each other rather than compete with each other (Scott-Phillips et al., 
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2011). For example proximate explanation why women prefer cues of genetic quality 
during fertile phase could be that men of high genetic quality are seen as attractive, 
whereas ultimate explanation for the same question could be that preference shift  
has been advantageous in evolutionary history and increased the quality of offspring, 
thus increasing the fitness of the woman. Dual mating theory attempts to explain why 
the preference shift has evolved and takes no stand on what mechanism causes the 
shift to happen. There are also various evolutionary (e.g. cost of getting caught) and 
social reasons not to cheat in relationship and most do not engage in adultery, 
cyclically or otherwise.   
Testosterone dependent traits have been hypothesized to be honest signals of genetic 
quality in males, as they may signal immunocompetence (Folstad & Karter, 1992; 
Thornhill & Gangestad, 1996) and several studies have found support for dual mating 
strategy theory using testosterone dependent secondary sexual traits (Johnston, 
Hagel, Franklin, Fink, & Grammer, 2001; Penton-Voak & Perrett, 2000; Penton-Voak et 
al., 1999). Although dual mating hypothesis has been influential in research of human 
sexual selection, recently studies with more rigorous statistical methods and  larger 
sample sizes in comparison with earlier studies have failed to replicate results 
supporting dual mating strategy hypothesis (Jones et al., 2018; Marcinkowska et al., 
2016; Marcinkowska, Galbarczyk, & Jasienska, 2018; Stern, Gerlach, & Penke, 2020) 
and earlier results have been criticized for their methods (Gangestad et al., 2016; 
Jones, Hahn, & DeBruine, 2019). As there are mixed results in the field more studies 
are needed to address the controversy and to better understand psychology of human 
mate preference. In the current study dual mating hypothesis is tested using larger 
sample size in comparison with earlier studies reporting significant findings and using 
two different cues of genetic quality, androstadienone and facial masculinity.  
1.1. Mate choice 
 
Due to mate choices crucial part role in reproductive success it has been studied 
extensively in evolutionary psychology. Among species in which there exists 
asymmetry in cost of having an offspring, usually sex that invest more on the offspring 
tends to be “choosier” and the sex that invests less competes among members of the 
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same sex over mating opportunities with individuals of the other sex (Trivers, 1972). In 
most species, including humans, sex that produces larger gametes (females) tend to be 
choosier and sex with smaller sex cells (males) tend to compete with each other over 
access to the other sex, although this can be reversed if the sex with smaller sex cells 
invest more in the offspring (Trivers, 1972). Trivers (1972, p.55) has defined parental 
investment as “any investment by the parent in an individual offspring that increases 
the offspring's chance of surviving (and hence reproductive success) at the cost of the 
parent's ability to invest in other offspring”, as the investment can be done before or 
after parturition and can be anything from metabolic investment in form of gamete 
size to any behavior that aids offspring’s survival,  such as feeding or guarding.  
As sexes differ in the mandatory investment in their offspring, their strategies for 
maximizing reproductive success differ from another (Buss & Schmitt, 1993). 
Hypothetically only limiting factor for men’s reproductive success is the number of 
available fertile women, as the benefit of a potential offspring outweighs the meager 
cost of copulation. According to sexual strategies hypothesis using a short-term mating 
strategy can be beneficial for men in terms of fitness when compared to forming a 
long-term relationship and investing to an offspring. A father of one can double the 
amount of his offspring by using short term mating strategy without bearing the costs 
of rearing an offspring, assuming that the offspring from short-term mating survives 
without parental investment from father.  Using short term mating strategy does not 
exclude the use of long-term mating strategy either alternatively, or at the same time.  
For women the situation is more complicated as copulation can lead to pregnancy, 
which is costly, has risks and hinders future reproduction for as many as several years 
(Buss & Schmitt, 1993). Thus, as the minimal parental investment for women is 
significantly larger, women should invest in the offspring quality and the resources that 
a man can provide to alleviate the costs of childbearing (Buss & Schmitt, 1993). Sexual 
strategy theory predicts that women should prefer both signals of willingness to invest 
in offspring and to cues of genetic quality.  
It is worth mentioning that the above are generalization, and men can, and indeed do 
invest heavily in offspring compared to other mammals (Buss & Schmitt, 1993; Geary, 
2000). After birth men can invest in the offspring by protecting and provisioning, and 
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variation in investment within both sexes is considerable (Buss & Schmitt, 1993). 
Hence, even though men and women differ in parental investment, differences are 
smaller compared to other mammals. 
 
1.2. Potential cues of male reproductive fitness 
 
Masculine traits are potential cues for male reproductive fitness  as testosterone may 
have immunosuppressive effect (Folstad & Karter, 1992; Thornhill & Gangestad, 1996; 
but for controversial results see Nowak, Pawłowski, Borkowska, Augustyniak, & Drulis-
Kawa, 2018). Rationale here is that testosterone dependent secondary sexual 
characteristics are honest signals of health and genetic quality. Honest signals are 
traits that convey useful information from the signaler to the recipient but also bear a 
cost for the signaler (Lindström & Kotiaho, 2002). If signaling is costly for the signaler, 
those with better genetic quality are able to exhibit these traits to a greater extend 
compared to individual with lower genetic quality as individuals with lower genetic 
quality are unable to bear the cost inflicted from the trait. As the trait cannot be used 
for deceivable signaling, it can be used for example assessing quality of a potential 
mate (Zahavi, 1975), like peahen evaluates suitor by the size of its tail feathers. 
As testosterone may have immunosuppressive effect, those with sound immune 
system are able to exhibit more prominent secondary sexual characteristics, making 
these traits honest signals of immunocompetence (Thornhill & Gangestad, 1996) and 
some of these secondary sexual characteristics traits have been linked to health (Foo, 
Simmons, & Rhodes, 2017; Rhodes, Chan, Zebrowitz, & Simmons, 2003).  
 
1.2.1. Facial attractiveness and dimorphism 
 
Differences between average male and female faces can be attributed to different 
levels of sex hormones. These differences start to show in puberty (Rhodes, 2006). 
Males typically have a larger jaw, cheekbones and brow ridges which are linked to 
testosterone, whereas in females aforementioned characteristics are smaller and 
linked to estrogen (Rhodes, 2006). Facial attractiveness has been hypothesized to 
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signal fertility in females (Law Smith et al., 2006), and health in males (Foo et al., 2017; 
Rantala et al., 2012; Rhodes et al., 2003; Thornhill & Gangestad, 2006) although there 
is inconsistency in the reported strength of the link (Foo et al., 2017; Rantala et al., 
2012). 
First studies regarding women’s preference for facial dimorphism reported that 
women preferred more feminine faces (Penton-Voak et al., 1999; Perrett et al., 1998), 
but later studies found the opposite result (Foo et al., 2017; Johnston et al., 2001; 
Jones et al., 2018). In addition to levels of sex hormones male faces may also signal 
other characteristics relevant to mate selection. Facial masculinity has been linked to 
decreased perceived and actual interest in infants (Roney, Hanson, Durante, & 
Maestripieri, 2006) and less commitment into a relationship (Boothroyd, Jones, Burt, & 
Perrett, 2007).  
1.2.2. Chemosignals 
 
Chemosignals are chemical compounds (molecule or mixture of molecules) (Wyatt, 
2014) that transmit information from releaser to receiver. Benefits of chemical 
communication include low cost of production compared to other modalities and 
variation in signal duration. Social communication via chemical signals is important in 
most mammals (Petrulis, 2013) and is known to affect behaviors including 
reproduction, maternal care/ parent-offspring communication, aggression and alarm 
responses (Petrulis, 2013). Although social chemosignaling is widely accepted in other 
mammals, there is ongoing debate whether humans possess an ability to communicate 
with chemosignals and what kind of role does this kind of communication have in 
social interaction. 
Some chemosignals (some formerly called pheromones) are thought to signal mate 
quality. In humans there exist sex differences in relation to chemosignals, as men have 
larger apocrine glands (Doty, Green, Ram, & Yankell, 1982), but women have 75% more 
apocrine glands (Brody, 1975). The amount of microbes in axillae begins to differ in 
puberty; men tend to have more microbes than women (Marples, 1982; Somerville, 
1969). Men’s sweat also contains more androstadienone and androstanol (Gower & 
Ruparelia, 1993), that are derivates of testosterone. The fact that these glands become 
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active at puberty, same time as axillary and pubic hair start to grow, supports the idea 
that these compounds may be used for chemical communication (Lübke & Pause, 2015; 
Wyatt, 2015). 
As male chemosignals are thought to be derivatives of testosterone (for example 
androstadienone) or to include derivatives of testosterone, they have been studied in 
mate choice context as honest signals. Male chemosignals have been shown to 
increase women’s evaluations of male attractiveness (Ferdenzi, Delplanque, 
Atanassova, & Sander, 2016; Saxton, Lyndon, Little, & Roberts, 2008; Thorne, Neave, 
Scholey, Moss, & Fink, 2002) but not all studies have been able to find the effect (Hare, 
Schlatter, Rhodes, & Simmons, 2017).  It is also noteworthy that in study conducted by 
Ferdenzi et al. (2016) androstadienone also increased male evaluations of female face 
attractiveness, and thus effect may not be sex specific.  
1.2.3. Dark side of masculinity 
 
Masculinity has been linked to various traits that are beneficial for the mate choice, 
but there are also drawbacks as masculinity may negatively affect parental investment. 
Males that exhibit strong physical signs of masculinity report more infidelity (Rhodes, 
Morley, & Simmons, 2013),  show preference for short-term relationships (Arnocky et 
al., 2018) and are perceived to have decreased qualities as a parent (Perrett et al., 
1998). In addition, masculinity has been linked to increased competitiveness (Archer, 
2009) and dominance (Geniole, Denson, Dixson, Carré, & McCormick, 2015), which can 
be advantageous in intrasexual competition, and thus be desirable attributes for an 
offspring, but are not necessarily desirable traits in long-term partner. 
Thus, it seems that women face problem in mate choice, where potential “good genes” 
for the offspring are accompanied by undesirable behavior traits in the father. As 
optimal mating strategy for men differs from that of women, according to sexual 
strategy theory (Buss & Schmitt, 1993) male with high genetic quality should favor 
short term mating strategy, and thus be willing to invest in the offspring in terms of 
good genes, but be reluctant to invest in the offspring in the long term. Likewise, male 
with lesser genetic quality cannot utilize short-term mating strategy, and hence be 
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willing to invest in the offspring through long-term investments, such as provisioning 
and protection.  
1.3. Dual mating strategy 
 
In the situation described in earlier chapter natural selection could have favored a 
female who formed a long-term relationship with a male willing to invest but obtained 
good genes outside the relationship. Dual mating strategy (Pillsworth & Haselton, 
2006) suggests that to gain both, good genes and parental investment, women should 
prefer cues of genetic quality (including masculinity) near ovulation when conception 
is likely and prefer more feminine traits in other phases of menstrual cycle. Thus, 
women could get the parental investment from the long-term relationship, and the 
good genes from another male via adultery, though strategy like this has its risks, as 
infidelity may end the long-term relationship leaving women without parental 
investment. Main point of the theory is that slight changes in behavior could 
(theoretically) maximize the fitness of women and offspring. It should be emphasized 
that ultimate level explanations answer questions regarding the reason why a trait has 
evolved and what adaptive problem it solves. Ultimate level explanations should not 
be used to explain individual behavior and no moral judgements should be made 
based on ultimate level explanation. 
Near ovulation women are shown to prefer masculine faces (Johnston et al., 2001; 
Penton-Voak & Perrett, 2000; Penton-Voak et al., 1999),  bodily masculinity (Little, 
Jones, & Burriss, 2007), voices of more masculine males  (Feinberg et al., 2006) and 
odors of self-reported dominant males (Havlicek, Roberts, & Flegr, 2005). Additional 
evidence for the theory comes from studies that have linked the preference shift 
towards masculinity to hormonal changes associated to menstrual cycle, such as 
estradiol (Johnston et al., 2001; Roney & Simmons, 2008; Roney, Simmons, & Gray, 
2011), testosterone (Lisa L. M. Welling, Jones, DeBruine, et al., 2008) and cortisol levels 
(Ditzen, Palm-Fischbacher, Gossweiler, Stucky, & Ehlert, 2017), which all fluctuate 
during menstrual cycle. Thus, it can be hypothesized that these changes in preferences 
for facial dimorphism are caused by hormonal fluctuations.  
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Dual mating strategy has also consequences regarding use of hormonal contraceptives, 
as hormonal contraceptives can “smoothen” hormonal variation (Alvergne & Lummaa, 
2010). Some studies have found that women using hormonal contraceptives do not 
show preference for facial or vocal masculinity (Feinberg, DeBruine, Jones, & Little, 
2008; Little, Jones, Penton-Voak, Burt, & Perrett, 2002; Penton-Voak et al., 1999), as 
normally ovulating women do, but others have reported contradictory results (Cobey, 
Little, & Roberts, 2015; Jones et al., 2019). It has even been proposed that use of 
hormonal contraceptives may cause problems in relationship. If hormonal 
contraceptive use affects masculinity preference, either starting or stopping the use of 
hormonal contraceptives during relationship would change the mate preference, 
potentially leading to dissatisfaction in current relationship (Roberts et al., 2014). 
1.3.1. Critique of dual mating hypothesis  
 
Although dual mating strategy theory has been influential regarding women’s mating 
tactics, recently there has been critique of the methodology of earlier studies 
regarding dual mating theory. Jones et. al. (2019) argue that earlier studies have used 
too small of a sample size in addition to using self-reported information regarding 
menstrual cycle and between subjects design. For example earlier studies linking cycle 
phase and increased preference for masculinity have had sample size smaller than 50 
(Johnston et al., 2001; Penton-Voak et al., 1999) or have used only one set of pictures 
to evaluate masculinity preference (Penton-Voak & Perrett, 2000).  According to 
Gangestad et al. (2016)  the small sample sizes and thus inadequate statistical power 
make it hard to interpret the earlier findings. In addition a growing number of studies 
using more rigorous methods have reported null-findings regarding facial masculinity 
(Jones et al., 2018; Marcinkowska et al., 2016, 2018),  masculine behavior (Stern et al., 
2020)  and vocal masculinity (Jünger et al., 2018). Also, two meta-analyses have been 
conducted using largely overlapping studies.  One found positive results for preference 
shift reporting a small effect size (Gildersleeve, Haselton, & Fales, 2014), and the other 
did not find support for dual mating strategy (Wood & Carden, 2014) adding up to the 
controversial results.  
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There is also ambiguity in research regarding hormonal contraceptives. Two within 
subject studies have been conducted, first reporting that hormonal contraceptive 
users prefer more feminine faces, and hormonal contraceptive users partners have 
more feminine faces in comparison with normally ovulating women (Little, Burriss, 
Petrie, Jones, & Roberts, 2013). However, the later and larger, study failed to replicate 
the earlier results (Jones et al., 2018). Also, study conducted by Jones et. al. (2018) 
showed that taking “placebo” (inactive pills containing no hormones) did not affect the 
preference. Even though dual mating strategy hypothesis has been widely accepted 
and studied, in the light of the recent findings it seems that the evidence it has might 
be due to false positives, underpowered studies and publication bias. 
   
1.4. Current study 
 
Aim of the current study is to test dual mating strategy hypothesis using two potential 
markers of genetic quality, facial masculinity and putative chemosignal 
androstadienone using placebo controlled, double-blind between subjects design with 
larger sample size (81) in comparison with earlier studies reporting significant results. 
First, we investigate if women in fertile phase of the cycle show increased preference 
for facial masculinity compared to women in non-fertile phase, as dual mating strategy 
suggests. Also we test if hormonal contraceptive users would differ from either fertile 
or non-fertile group as earlier studies have yielded contradictory results (Jones et al., 
2018; Little et al., 2013).  
Secondly, we test if androstadienone alters women’s evaluations for male facial 
attractiveness depending on fertility status. If androstadienone is a signal of genetic 
quality, according dual mating hypothesis women should prefer it during fertile phase 
of the cycle as by preferring the cue women would also prefer males with high genetic 
quality, that emit the signal. One possible way for this is if exposure to 
androstadienone increases women’s perceived attractiveness of male faces as shown 
in earlier studies (Ferdenzi et al., 2016; Saxton et al., 2008). Also, in accordance with 
earlier studies regarding hormonal contraceptive use, we hypothesize that women 
using hormonal contraceptives show decreased preference for masculinity in 
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comparison with groups not using hormonal contraceptives (for a review on 
contaceptives effect on mate choice, see Alvergne & Lummaa, 2010). 
Thirdly, as earlier studies using male chemosignals (Ferdenzi et al., 2016; Thorne et al., 
2002) have yielded mixed results regarding menstrual cycle and reported effect that is 
not dependent on menstrual cycle. To address this controversy, we test if 
androstadienone increases perceived attractiveness of male faces, not dependent on 
menstrual cycle.  
Lastly, we investigate if androstadienone would enhance the preference for facial 
masculinity. As both, androstadienone and facial masculinity are thought to signal 
genetic quality either via immunocompetence or enhanced intra-sexual competition, a 
male with masculine face should also have more derivatives of testosterone in his 
body odor and vice versa. Hence, we hypothesize that androstadienone would 
increase the female preference for facial masculinity.  
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2.METHODS 
 2.1. Participants 
 
Total of 82 heterosexual female Finnish students participated in the study (mean age 
23.17, range 19-35) differing in fertility status. Participants were recruited via university 
email lists and word of mouth. Of the 82 participants one was excluded from the 
analysis, as she did not fill the first questionnaire regarding masculinity preference. Of 
the remaining participants 17 were in the fertile phase of their cycle, 30 were in the non-
fertile phase and 34 were using hormonal contraceptives, including combined oral 
contraceptives (27), intrauterine device (3), mini pills (4). Half (41) of the participants 
were exposed to androstadienonone, of which 12 were in the non-fertile phase, 11 were 
in fertile phase and 18 used hormonal contraceptives. From the other half (40) who were 
in placebo condition 18 were in the non-fertile phase of menstrual cycle, 6 were in the 
fertile phase and 16 used hormonal contraceptives. All participants signed an informed 
consent form. Exclusion criteria included dysnosmia, smoking, a history of nasal trauma 
or brain injury as these may decrease potential effectiveness of androstadienone. 
2.2. Materials  
2.2.1. Androstadienone 
 
Androstadienone was obtained from Steraloids incorporated (Newport, RI). Thirty (30) 
mg of crystallized androstadienone was put to a opaque jar as done in previous 
experiments (Huoviala & Rantala, 2013; Wyart et al., 2007) and was stored in room 
temperature and kept protected from light.   
In order to make the androstadienone smell similar to the control substance, 30mg of 
yeast was mixed into androstadienone, and control stimulus contained 60 mg of dry 
yeast, as done earlier by Huoviala & Rantala (2013). 
2.2.2. Individual pictures 
 
Full face pictures of 40 Caucasian males were taken in controlled environment regarding 
the lighting and background. Pictures were then rated for attractiveness by female 
raters, and in that order every second picture was selected for set A and rest of the 
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pictures formed set B. This was done to ensure that pictures were similar in 
attractiveness. The order of pictures was counterbalanced so that half of the 
participants saw set A before and set B after administration of androstadienone or 
placebo and other half of participants saw the pictures in contrariwise manner. 
2.2.3. Picture pairs 
 
Picture pairs were formed from 40 full face pictures featuring Caucasian males. Full 
face pictures were photographed in similar fashion as described earlier. Specialist 
software (Tiddeman, Burt, & Perrett, 2001) was used in order to calculate the vector 
differences between the average male and female faces. Then 25% of these 
differences were either subtracted or added to the full face pictures as done in earlier 
studies, although the amount of morphing has varied  (Jones et al., 2018; Penton-Voak 
& Perrett, 2000; Penton-Voak et al., 1999; Perrett et al., 1998; Lisa L. M. Welling, 
Jones, Debruine, Little, & Smith, 2008).  Face pairs were created using feminized and 
masculinized version of the same face. Figure 1. demonstrates picture pairs used. Two 
sets of 20 pairs were formed with randomized order to rule out order effects. 
Individual pictures and face pairs were formed using pictures of different individuals so 
there was no overlap between them, and each participant saw each face only once 
during the experiment. 
 
Figure 1. Example of face pairs used. On the left side face is 25% feminized from the 
original picture and right one is 25% more masculinized from original face.  
14 
 
2.3. Procedure 
 
 
 
Figure 2. Procedure of the study. 
 
Study was conducted as placebo controlled, double-blind between-subjects design. 
Experiment took place in an air-conditioned room, between 12:00 and 18:00 and each 
session lasted around 60min. 
After signing the consent form, the procedure of the study was explained to the 
participant and also provided in writing. After confirming that the participant had 
understood the instructions, experimenter “turned on” the video camera, that was used 
to create an impression that participant is monitored throughout the experiment, 
although the camera was not actually on. Then the experimenter left the room for the 
rest of the study. 
Experiment started with participants evaluating the attractiveness of 20 pictures of male 
faces from a laptop computer screen. Attractiveness was rated in scale from -5 (very 
unattractive) to 5 (very attractive). After completing ratings of  individual pictures, 
participants were shown 20 face-pairs, consisting of different faces than the individual 
pictures, and participants were instructed to select the more attractive one from the 
pair by marking the number of that picture (1 or 2) to the answer sheet. All the pictures 
presented to the participant were shown in the middle of the screen using Microsoft 
PowerPoint. Participants had no time limit to rate the pictures and proceeded from 
Instructions 
First evaluation of 
attractiveness and 
masculinity preference 
20 minute video 
Second evaluation 
of attractiveness 
and masculinity 
preference 
Final questionaire  
Treatment 
(sniffing) 
Ultimatum and 
dictator games 
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picture to picture by hitting space bar and provided answers to attractiveness ratings 
and masculinity preference with pen and paper to the answer sheet. 
When participants had completed all 20 face pairs, they were instructed to open the 
sealed opaque jar containing either androstadienone or control and were instructed by 
computer program to sniff the jar 20 times for 5 second each time, taking every other 
sniff with right nostril and every other with left nostril, so that total of 10 sniffs were 
taken with left nostril and 10 with right nostril. 
After being exposed to the treatment, participants watched a 20min relaxing aquatic 
video as done in previously by Huoviala & Rantala (2013). Aim of the video was to make 
sure that androstadienone had enough time to take effect. As exposure to chemosignals 
can be seen in hormone levels after 15min of the exposure (Cerda-Molina, Hernández-
López, de la O, Chavira-Ramírez, & Mondragón-Ceballos, 2013). 
After the video participants task was to rate another set of 20 pictures of individual faces 
for their attractiveness. Following that, 20 face-pairs (again taken from different 
individuals than individual pictures) were shown and again participants were to choose 
the more attractive one from the masculinized and feminized faces. Between the face-
pairs participants were instructed to sniff the treatment solution, to keep the exposure 
constant. 
Following the second face pair evaluation participants played two rounds of one-shot 
ultimatum game, both as proposer and as receiver and one round of dictator game, as 
proposer. This data will not be included to the analysis as it is out of the scope of this 
master thesis, but It is mentioned here as it affected the procedure. 
After three rounds, participants filled in a short questionnaire regarding age, sexual 
orientation, the pleasantness and intensity of the odor stimuli, the usage of 
contraceptives and the current phase as well as usual length of their menstrual cycle.  
2.3. Statistical analyses 
 
IBM SPSS version 25 for WindowsTM software (IBM Corp, 2017) was used in all the 
analyses. 
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2.3.1. Variables 
Odor intensity and pleasantness 
 
In order to verify that masking of the androstadienone was successful participants were 
asked to rate the pleasantness and intensity of the stimuli. Both variables were 
evaluated from 1 to 10, one meaning weak intensity or unpleasant smell and 10 meaning 
very strong smell or very pleasant smell. 
Within subject variables 
 
From face evaluations 4 variables were formed. Attractiveness_before was formed by 
measuring the average attractiveness for all the 20 pictures rated before the treatment. 
In similar fashion attractiveness_after treatment was the average of the ratings for all 
the 20 pictures after treatment.  
For the masculinity preference_before and preference_after the treatment were 
calculated by summing all the times when participant had chosen the more masculine 
face and then dividing that by total amount of face pairs (20). Variable is thus a 
percentage of how many times masculinine face was favored over more feminine face.  
Between subjects’ variables 
 
Participants provided information about the length of their menstrual cycle and the day 
of the last menses and fertility was calculated using assumptions that luteal phase lasts 
14 days, and fertile phase does not exceed 6 days (Wilcox, 2000). The fertility variable 
was calculated only for normally ovulating participants. Fertility variable was created 
using aforementioned variables, with three levels, fertile phase, non-fertile phase and 
use of hormonal contraceptives. 
 
2.3.2. Analyses of odor pleasantness and intensity 
 
Odor pleasantness and intensity were compared between experimental and control 
condition to ensure that potential effects were results of the compounds and not 
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results of differing pleasantness or intensity. Homogeneity of variance was tested 
using Levene’s Test of Homogeneity of Variance (odor_pleasantness p = .631, 
odor_intensity p = .594). Normality was tested using Kolmogorov-Smirnov test of 
normality and both variables failed to meet the normality assumption regarding 
pleasantness (androstadienone_pleasantness p = .001, control_pleasantness p < .001) 
and intensity (androstadienone_intensity p = .001 ;control_intensity p = .012). 
Intensity was perceived as relatively high and odour pleasantness was perceived as low 
in both groups thus the distribution is skewed in both cases. Both variables were 
transformed using natural logarithm, but the normality assumptions wasn’t met in 
either pleasantness (androstadienone_pleasantness p = .025, control_pleasantness p = 
.006) or intensity (androstadienone_intensity p < .001 ;control_intensity p = .010) and 
thus a non-parametric Mann-Whitney U-test was used.  
2.3.3. Analyses of attractiveness evaluations and masculinity preference 
 
Attractiveness ratings before treatment failed to meet the assumption regarding 
homogeneity (Levenes test, p = .009) but attractiveness ratings after treatment met 
the assumption (Levenes test, p = .059). Both masculinity ratings, before and after 
treatment met homogeneity assumption (Masculinity rating before, Levenes test, p = 
.431 ; Masculinity rating after Levenes test, p = .229).  
Differences in attractiveness ratings were analyzed using 2 (time) x 2 (treatment) x 3 
(fertility) mixed model ANOVA. Time was within subject variable and it had had two 
levels, before treatment and after treatment. Treatment and fertility were between 
subject variables, and treatment had two levels, treatment and control, and fertility 
had three levels, non-fertile phase, fertile phase and hormonal contraceptive use.  
Masculinity preference was also analyzed using 2 (time) x 2 (treatment) x 3 (fertility) 
mixed model ANOVA with the same levels as mentioned above.  
In order to minimize the number of hypotheses tested and to avoid false positives, 
only those comparisons that test aforementioned hypotheses are reported. Further as 
running multiple variance analyses increases the risk of a false positive and a potential 
consequence of failing to meet the homogeneity assumption is that the observed p-
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value may decrease alpha level .01 was used instead of .05 while interpreting results 
from both ANOVAs.  
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3. RESULTS 
3.1. Odor masking 
 
Odors did not differ in terms of perceived pleasantness (U=746.5, p = .479, d = .16) or 
intensity (U = 724.0 p = .359, d = .20). As there were no differences in perceived odor 
pleasantness or intensity, potential effects of androstadienone are unlikely to be 
results of differing qualities of odors. Cohens d was calculated using calculator 11 in 
psychometrica.de. 
  
3.2. Between group differences in perceived attractiveness and masculinity 
preference 
 
Mixed model of variance analysis was conducted for both attractiveness and 
masculinity preference.  
3.2.1. Attractiveness ratings 
 
Analysis showed no interaction between time and treatment F(1,75) = .11, p = .739, ηp2 
= .001, or main effect for fertility, F(2,75) = .86, p = .428, ηp2 = .02. Also no interaction 
between time, treatment and fertility was found F(2,75) = .28, p = .760, ηp2 = .01. 
Results are illustrated in Table 1.  
3.2.2. Masculinity preference 
 
Analysis revealed no interaction for time and treatment, F(1,75) = 2.67, p = .107, ηp2 = 
.03  and no main effect was found for fertility F(2,75) = 2.94, p = .059, ηp2 = .07 
Also no interaction was found between time, treatment and fertility, F(2,75) = 2.11, p = 
.128, ηp2 = .05. Results are illustrated in Table 1. 
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Table 1. Descriptive statistics of attractiveness ratings and masculinity preference before and after treatment. 
    
 
Fertility   
       
 Low High Contraceptives 
       
 Mean SD Mean SD Mean SD 
              
 Attractiveness ratings 
       
Androstadienone group before -2.00 [-2.69, -1.31] 1.21 -1.49 [-2.15, -.83] 1.11 -1.72 [-2.02, -1.42] .66 
       
Androstadienone group after -1.95 [-2.6, -1.3] 1.15 -1.35 [-1.86, -.84] .84 -1.50 [-1.93, -1.07] .94 
       
Control group before -1.26 [-1.87, -.65] 1.33 -1.34 [-1.97, -.71] .79 -1.68 [-1.97, -1.39] .59 
       
Control group after -1.21 [-1.84, -.55] 1.46 -1.48 [-2.72, - .24] 1.55 -1.36 [-1.80, -.96] .85 
       
 Masculinity preference (%) 
       
Androstadienone group before 55.4 [46.9, 64.0] 16.5 59.1 [52.5, 66,0] 13.6 59.1 [52.5, 66,0] 3.81 
       
Androstadienone group after 46.7 [39.6, 53.7] 12.5 58.7 [43.6, 73.7] 25.5 58.7 [43.6, 73.7] 3.46 
       
Control group before 61.1 [53.0, 69.5] 16.5 30.0 [15.4, 44.3] 17.9 30.0 [15.4, 44.3] 2.68 
       
Control group after 66.4 [56.6, 76.0] 21.2 40.0 [29.9, 50.1] 12.7 40.0 [29.9, 50.1] 3.55 
              
       
Confidence interval reported is 95%     
Masculinity preference means are reported as %    
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4. DISCUSSION 
 
Firstly, in current study we did not find preference shift regarding facial masculinity 
between menstrual cycle phases, despite using larger sample size than some of the 
earlier studies, which is in line with recent studies also reporting non-significant results 
(Jones et al., 2018; Marcinkowska et al., 2016, 2018).  Also, in current study no 
evidence was found that hormonal contraceptive use would decrease masculinity 
preference as group using hormonal contraceptives did not differ from normally 
ovulating groups regarding preference for facial masculinity. Although many earlier 
studies have reported decreased preference for masculinity in hormonal contraceptive 
users (Feinberg et al., 2008; Little et al., 2002; Penton-Voak et al., 1999), there are 
contradicting results (Cobey et al., 2015; Jones et al., 2018). Most notably in a within-
subject study by Jones et al. (2018) negative effect was found, contradicting the idea 
that hormonal contraceptive use would decrease masculinity preference. If the effect 
were robust, contradicting results (especially in well conducted study using large 
sample size) would be unlikely. This suggest that either the effect is not robust, or that 
there is no effect. Result of current study did not find support for the idea that 
hormonal contraceptive use decreases masculinity preference and as there are 
contradicting results on the matter studies using larger sample sizes and within-subject 
design are needed to resolve the controversy.  
Secondly, in current study androstadienone did not affect attractivity evaluations 
depending on phase of menstrual cycle or use of hormonal contraceptives as dual 
mating strategy predicts.  Earlier studies (Ferdenzi et al., 2016; Thorne et al., 2002) 
have also reported no clear effect between fertility and androstadienone, and to this 
date there is no clear evidence that androstadienones effects  are dependent on 
fertility. Also, no main effect was found for androstadienone regarding facial 
attractiveness as we hypothesized, adding up to the findings of Hare et. al. (2017). In 
current study 30mg of androstadienone was used, which is larger amount than 
typically found in male axillae (Gower & Ruparelia, 1993), and its it unlikely that null 
findings are due to a weak signal. To this date 2 out of 4 studies (including current one) 
report significant findings (Ferdenzi et al., 2016; Saxton et al., 2008), and study 
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conducted by Saxton et al. studied androstadienone´s effect in speed dating, instead of 
laboratory settings and is thus more susceptible to confounding variables. It Is possible 
that androstadienone increases perceived attractiveness, but studies investigating the 
issue with small sample sizes may have been underpowered and therefore it is hard to 
make correct statistical inferences based on them.  
Lastly, no main effect was found androstadienone regarding facial masculinity. This 
part of the study was entirely novel, and rationale was that androstadienone would 
increase preference for facial masculinity, as these two traits can be expected to 
appear together. On the grounds of this study there is no compelling evidence that 
androstadieonone would alter preference for masculinity. 
It is of special importance to point out that current study’s (and of those published 
earlier) results regarding androstadienone are tricky to interpret as three possible 
explanations arise. One is that androstadienone does not signal genetic quality, and 
nothing can be said about dual mating strategy. Second one is that androstadienone 
does signal genetic quality and the results do not support dual mating theory. Last 
possible explanation is that there is interaction between androstadienone and 
menstrual cycle, but studies have not been able to find the effect. Evidence for 
androstadienones role as chemosignal is scarce as only 4 studies (including current 
study) have been conducted regarding intra-sexual competition and half of these 
studies have failed to find the effect (andostadienone is discussed in greater extend 
below). Dual mating theory has also met recent critique (for a review, see Jones et al., 
2019) and thus it is hard to interpret the results as neither, androstadienone or dual 
mating strategy theory, seem to have strong support behind them. 
There has also been critique for use of synthetic chemosignals (or pheromones), most 
notably no peer reviewed bioassay has been reported where androstadienone (instead 
of any other compound found in axillae) acts as chemosignal (Wyatt, 2015). For  a 
more comprehensive critique, see review by Wyatt (2015). One study has found that 
chemosignals collected from male axillae positively altered female evaluations of male 
faces (Thorne et al., 2002). It is possible that chemosignals collected from axillae may 
alter the evaluations of attractiveness, but, once again, more studies are needed in 
that matter. Current study failed to find effect for androstadienone, and in the future a 
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larger study using within-subjects paradigm should be conducted to address whether 
androstadienone plays a role in human chemosignaling. 
Recently growing number of studies have failed to find support for dual mating 
strategy hypothesis. In current study no support for dual mating hypothesis was found, 
albeit two different signals of genetic quality were used, and a larger sample was 
collected. These findings are in line with recent studies, that have used within subject -
paradigm and larger sample sizes. In a comprehensive review Jones et. al. (2019) have 
pointed out methodological problems in studies reporting significant results regarding 
dual mating strategy hypothesis, mainly low statistical power due small sample size 
and use of between subject -design. As the statistical power of earlier studies has been 
low, it is probable that significant results are due false positives which is supported by 
larger studies failing to replicate these earlier results (Jones et al., 2018; Jünger et al., 
2018; Marcinkowska et al., 2016, 2018; Stern et al., 2020). Thus, although dual mating 
strategy has been influential in human mating psychology it does not have strong 
empirical support.  
 As suggested by Jones et al. (2019) in the future studies should test dual mating 
hypothesis against alternative hypothesis such as “estrous” model (Havliček, Cobey, 
Barrett, Klapilová, & Roberts, 2015) as currently there is not clear evidence for dual 
mating strategy, and studies reporting negative effects, and thus contradicting dual 
mating strategy, are scarce (Harris, 2013; Zietsch, Lee, Sherlock, & Jern, 2015).  Estrous 
model suggests that instead of change in masculinity preference, near ovulation 
interest in sex would be greater. Thus, according to “estrous model” there is no 
adaption for obtaining good genes while maintaining support from another individual, 
but rather a by-product of shared ancestry with other primates that have increased 
sexual motivation during estrous. 
 
4.1. Limitations of the study 
  
Most notable limitation of the current study is self-reporting of menstrual cycle. As 
noted in Gangestad et al. (2016) calculating timing of ovulation from  last menses is 
not accurate measurement of ovulation. Length of both follicular and luteal phase vary 
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among women, and even though fertile phase was calculated using 6 day fertile 
window, Gangestad et al. (2016) estimate methods validity to be notably lower 
compared to other techniques, such as confirming the day of menses after the 
experiment, or by using hormonal test.  As the validity is low, chance that there are 
participants who are not in fertile phase of the cycle in the fertile group is higher, as is 
the chance that someone in her fertile phase was in the non-fertile group. Hence using 
self-reported timing of ovulation can decrease the differences between fertile and 
non-fertile groups and lower statistical power of the study. 
Also using estimating timing of ovulation results in uneven group sizes. If all 
participants had regular cycles, using 6-day fertile window means that every fifth non-
contraceptive user would be in fertile phase. As not every woman has a 28-day cycle, 
and use of hormonal contraceptives is common, the fertile group ends up significantly 
smaller. In addition, if fertile group is split in half (treatment/control) this halves the 
already small group size. The fertile group in placebo condition had only 6 participants, 
which lowers the statistical power in the current study.  
Another limitation is the use of between-subjects design. To observe effect size of .5 
with 80% power would require sample size over 900 participants with between subject 
design while controlling for potential error in evaluating phase of cycle (Gangestad et 
al., 2016). As shown in meta-analysis by Gildersleeve et al. (2014), effect size of 
preference shift towards masculinity might be  closer to small (.2) than medium (.05). 
Thus, the current study’s probability to find a possible effect with 81 participants is 
low. For comparison Gonzalez and Ferrer (2016) estimated that sample size of 200 has 
statistical power of 20% to yield positive results if effect size is .05/medium.  On the 
grounds of  power analysis by Gangestad et al. (2016) and Gonzalez and Ferrer (2016), 
using between subjects -design decreases the statistical power significantly. At the 
time of collecting the data for the current study (2012) this issue was not widely 
known. Power analyses before data collection should be done in future studies.  
There are also some methodological aspects that should be considered while 
interpreting results. Evaluations of attractiveness and masculinity preference before 
and after the treatment were not done in identical settings, as participants were asked 
to sniff the jar between the pictures. This can be a confounding variable on current 
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study. Secondly the use of term attractive may have been ambiguous. As context 
(choosing short- and long-term partners) has been reported to potentially have an 
effect on preference (Penton-Voak et al., 1999) we cannot rule out the possibility that 
participants understood the term attractiveness differently. Some participants may 
have evaluated individual pictures thinking of suitability to short-term relationship, 
whereas others may have thought of attractiveness in long-term relationship. Another 
problem arises from use of only two pictures while evaluating masculinity preference. 
Although this method has been used in many earlier studies (Cobey et al., 2015; 
Penton-Voak et al., 1999; Perrett et al., 1998; L. L.M. Welling et al., 2007) it doesn’t 
address the individual variation. If a participant prefers more masculine faces overall, it 
is possible that in both phases, fertile and non-fertile, she prefers the more masculine 
picture in forced choice task, possibly weakening the statistical power in current study. 
Thus, we cannot conclude that tasks used in current study may not be reliable 
measurements of attractiveness and masculinity preference. 
Although facial characteristics are important factor in mate choice and have been 
studied widely (Johnston et al., 2001; Law Smith et al., 2006; Perrett et al., 1998), 
linking these characteristics to evolutionary important traits has resulted in 
contradictory findings. Male facial dimorphism (Rhodes et al., 2003; Thornhill & 
Gangestad, 2006)  and attractiveness (Foo et al., 2017) have been found to correlate 
with some aspects of health, such as mental health (Rhodes, 2006), sperm quality (Foo 
et al., 2017),  but most studies have relied upon questionnaires and validity of health 
measurements is questionable. Only study that used measures theoretically linked to 
sexual selection reported a weak link between facial attractiveness (predicted by facial 
dimorphism) and semen quality (Foo et al., 2017). Also male sex hormones have failed 
to show immunosuppressive properties (Nowak et al., 2018), questioning the link 
between testosterone dependent trait´s role as honest signal as well as potential  link 
between facial dimorphism and health. Hence it is possible that male face dimorphism, 
as female face dimorphism, signals fertility instead of overall health. It has also been 
suggested that masculinity is preferred not because of its connection to health but 
rather because its connection to dominance (Boothroyd et al., 2007). All in all, there is 
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no consensus why masculinity would be preferred nor is there strong evidence that 
masculinity signals health or fertility. 
Also, in current study amount of androstadienone was notably larger compared to 
naturally occurring amounts. One might criticize that effects found using amounts that 
exceed those occurring naturally tell nothing about real life effects of 
androstadienone. While this is true, as no effect was found, it can be interpreted that if 
androstadienone would act as signal, larger amount should elicit larger effect and 
hence using unnatural amount is not a problem while interpreting current results. 
Last limitation regards the sample of the current study. As normal population does not 
constitute of university students, our sample does not represent the whole population. 
In addition, current study had a convenience sample, as some of the participants were 
recruited via word of mouth. It is possible that some participants recruited by word of 
mouth were more prone to please the experimenter, for example by knowing the 
experimenter. No significant findings were found, so potential misrepresentation of 
population does not interfere with interpretation of results. 
4.2. Conclusion 
 
In conclusion, no support was found for either dual mating theory or 
androstadienone´s role as human chemosignal of genetic quality. Although current 
study may be underpowered regarding dual mating theory, at the time of collection of 
the data, methods used were common in this field of study and current had larger 
sample size than many of its predecessors. It has more recently been shown that 
earlier studies employed methods that were unlikely to have adequate statistical 
power, and studies done in the future should use larger sample size and employ 
within-subjects paradigm and more objective evaluation of  menstrual cycle phase. 
Current findings regarding dual mating hypothesis are in line with recent studies. In 
addition, no evidence was found for androstadienone`s role as chemosignal of genetic 
quality. We suggest future research to be directed towards potential alternatives of 
dual mating theory, such as estrous model. Regarding androstadienone, as the 
findings, seem ambiguous we suggest that following studies should address the issue 
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with larger sample size to resolve the ambiguity around androstadienone and to clarify 
if it actually acts as a human chemosignal.
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